Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12792062 | 0.84 | NPSR1 (0.40) | NPSR1KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL12792112 | 0.83 | KDM4E (0.49) | NPSR1KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL12792066 | 0.82 | L3MBTL1 (0.32) | NPSR1KDM4EL3MBTL1ALDH1A1 | |
| SCHEMBL10027554 | 0.81 | KDM4E (0.43) | MCL1KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL10027553 | 0.77 | KDM4E (0.55) | MCL1KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL12792024 | 0.76 | NPSR1 (0.37) | NPSR1KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL16674345 | 0.75 | KDM4E (0.38) | MCL1KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL23431347 | 0.74 | NPSR1 (0.44) | NPSR1KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL10027562 | 0.74 | DUSP3 (0.38) | MCL1KDM4EATML3MBTL1DUSP3 | |
| SCHEMBL12792053 | 0.74 | KDM4E (0.47) | NPSR1KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2293357-B1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2014-12-10 | — | — | EP | disclosed |
| US-20110057184-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-03-10 | — | — | US | disclosed |
| US-20110057184-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057184-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | LAS1L, EML4, OXA1L | NPSR1 4771/4885MCL1 3639/4885KDM4E 2598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.